Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chalice Brands was a vertically integrated cannabis company that operated primarily in the Oregon market, focusing on the cultivation, production, and retail of medical and recreational cannabis products. Formerly known as Golden Leaf Holdings, the company rebranded to Chalice Brands to align with its flagship retail brand, Chalice Farms. The company's business model encompassed the entire value chain, from high-tech cultivation and CO2 extraction to a network of proprietary retail dispensaries. Its product portfolio included oils, edibles, and flower designed for therapeutic and wellness applications. Following a period of significant financial distress and debt, the company entered a court-appointed receivership in May 2023, leading to the liquidation and sale of its operational assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chalice Brands.